FDG PET/CT in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma

Anaplastic large cell lymphoma (ALCL) is a rare non-Hodgkin's lymphoma, with rearrangements of the anaplastic lymphoma kinase gene in 60%-85% of systemic cases. We report an 11-year-old boy with ALCL in whom serial FDG PET/CT revealed partial response and complete metabolic response at interim and end of treatment, respectively. However, the patient relapsed within 2 weeks, confirmed by cytology. Because of the inherent aggressive nature of ALCL, possibility of an early relapse should always be kept in mind.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:45

Enthalten in:

Clinical nuclear medicine - 45(2020), 7 vom: 01. Juli, Seite 540-541

Sprache:

Englisch

Beteiligte Personen:

Angamuthu, Meivel [VerfasserIn]
Kaur, Kanwaljeet [VerfasserIn]
Tripathi, Madhavi [VerfasserIn]
Meena, Jagdish Prasad [VerfasserIn]
Seth, Rachna [VerfasserIn]
Kumar, Rakesh [VerfasserIn]

Links:

Volltext

Themen:

0Z5B2CJX4D
ALK protein, human
Anaplastic Lymphoma Kinase
Case Reports
EC 2.7.10.1
Fluorodeoxyglucose F18
Journal Article

Anmerkungen:

Date Completed 05.10.2020

Date Revised 06.02.2021

published: Print

Citation Status MEDLINE

doi:

10.1097/RLU.0000000000003071

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM309876494